Seppo W Langer Selected Research

Adenocarcinoma

1/2020	Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations.
1/2016	Primary pulmonary adenocarcinoma in a 16-year-old boy - a five-year follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seppo W Langer Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 08/2003
13	Lung Neoplasms (Lung Cancer) 12/2023 - 05/2008
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2014
6	Wounds and Injuries (Trauma) 01/2014 - 01/2006
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 05/2008
5	Neuroendocrine Carcinoma 01/2017 - 01/2012
5	Necrosis 11/2010 - 01/2003
4	Neoplasm Metastasis (Metastasis) 04/2024 - 05/2016
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2020 - 06/2015
3	Brain Neoplasms (Brain Tumor) 10/2012 - 08/2003
2	Adenocarcinoma 01/2020 - 01/2016
2	Cardiotoxicity 01/2014 - 01/2007
1	Disease Progression 04/2024
1	Residual Neoplasm 12/2023
1	Schwannomatosis 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Menorrhagia 01/2023
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2023
1	Edema (Dropsy) 01/2021
1	Carcinoid Tumor (Carcinoid) 01/2021
1	Lymphatic Metastasis 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Insulinoma 12/2019
1	Ganglioneuroblastoma 12/2017
1	Liver Diseases (Liver Disease) 05/2016
1	Atherosclerotic Plaque (Atheroma) 12/2015
1	Atherosclerosis 12/2015
1	Neutropenia 10/2012
1	Pulmonary Embolism 10/2012
1	Thrombocytopenia (Thrombopenia) 10/2012
1	Fibrosis (Cirrhosis) 02/2010
1	Pathologic Complete Response 05/2008

Drug/Important Bio-Agent (IBA)

10	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2024 - 12/2015
9	64Cu-DOTATATEIBA 01/2023 - 06/2015
8	Etoposide (VP 16)FDA LinkGeneric 03/2024 - 08/2003
8	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2014 - 08/2003
7	AnthracyclinesIBA 01/2014 - 01/2003
4	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 01/2012
4	Chromogranin AIBA 12/2023 - 01/2017
4	Topotecan (Hycamtin)FDA LinkGeneric 12/2023 - 05/2008
4	alovudineIBA 07/2022 - 12/2016
4	Immune Checkpoint InhibitorsIBA 04/2022 - 04/2017
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2021 - 12/2016
3	PlatinumIBA 12/2023 - 01/2017
3	LigandsIBA 12/2022 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 08/2003
2	Everolimus FDA Link 04/2024 - 12/2023
2	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
2	Glucagon (Glukagon)FDA Link 01/2021 - 12/2019
2	Ga(III)-DOTATOCIBA 03/2017 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2016
2	AntidotesIBA 08/2007 - 01/2007
1	lanreotide (Somatuline)FDA Link 04/2024
1	Peptide Receptors (Peptide Receptor)IBA 04/2024
1	Radioisotopes (Radionuclides)IBA 04/2024
1	Fluorouracil (Carac)FDA LinkGeneric 03/2024
1	Fluorine-18IBA 02/2024
1	Aspartic Acid (Aspartate)FDA Link 01/2023
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2023
1	IntegrinsIBA 01/2023
1	Factor VII (Proconvertin)IBA 12/2022
1	Thromboplastin (Tissue Factor)IBA 12/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	ProinsulinIBA 12/2019
1	Insulin (Novolin)FDA Link 12/2019
1	pentaerythrityl triacrylate (PETA)IBA 01/2018
1	SynaptophysinIBA 01/2017
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 07/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2015
1	Oxygen (Dioxygen)IBA 06/2014
1	Protein Kinase CIBA 10/2012
1	enzastaurinIBA 10/2012
1	AnthraquinonesIBA 02/2012
1	Vincristine (Oncovin)FDA LinkGeneric 01/2012
1	MelatoninIBA 11/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2010
1	IronIBA 02/2010
1	Cisplatin (Platino)FDA LinkGeneric 05/2008
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2006

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 04/2024 - 01/2003
15	Therapeutics 04/2024 - 01/2007
8	Radiotherapy 01/2022 - 10/2012
1	Operative Surgical Procedures 01/2024
1	Immunotherapy 01/2022
1	Drug Tapering 01/2022
1	Appendectomy 01/2021
1	Minimally Invasive Surgical Procedures 01/2021
1	Combined Modality Therapy 12/2017
1	Precision Medicine 12/2017
1	Radiofrequency Ablation 05/2016
1	Resistance Training 10/2013
1	Cranial Irradiation 05/2008